Eli Lilly Offers Designers $75k To Redesign Clinical Trial Info For Patients

Eli Lilly opens Clinical Trial  Visualization Redesign Challenge for designers & developers to make clinical trial information more patient-friendly.

Eli Lilly, one of the world’s largest pharmaceutical companies, invites designers and developers to reimagine clinical trial  information in a patient-centric way. As part of Lilly’s Clinical Open Innovation initiative, which calls on open innovation to help transform clinical research and development, challenge participants are now being asked to focus on the ideas and possibilities for envisioning clinical trial protocols from a patient’s point of view.

Clinical trial information can often be dense and difficult to digest from a patient’s perspective. Patients may have questions surrounding the risks and benefits of their participation in the trial, logistics, the role of their personal doctor, and much more. The goal is to redesign that information so that key aspects are highlighted in a visually appealing and user-friendly way.